Sponsor

University of Oklahoma

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name University of Oklahoma appears in 106 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials106
Recruiting shown18
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

60 shown
Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)NCT06960798 · lead sponsor · 2026-10-02
RECRUITING
Fiber mHealth Intervention for PrediabetesNCT07491653 · lead sponsor · 2026-08-01
RECRUITING
Biopsy-site-marker in Breast CancerNCT07833566 · lead sponsor · 2026-07-09
RECRUITING
Protoacoustic Imaging For 3D MappingNCT07832617 · lead sponsor · 2026-06-10
RECRUITING
Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate CancerNCT07014618 · lead sponsor · 2025-10-16
RECRUITING
Using Light Therapy for Mild Cognitive ImpairmentNCT07651787 · lead sponsor · 2025-10-01
RECRUITING
Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer SurvivorsNCT06651359 · lead sponsor · 2025-08-24
RECRUITING
Connect2Care: Prostate Cancer Education and Screenings for African American MenNCT07055165 · lead sponsor · 2025-07-26
RECRUITING
Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0NCT06488781 · lead sponsor · 2025-04-29
RECRUITING
Remote Physical Activity Programming to Improve Outcomes in Cancer Survivors With and Without Type 2 DiabetesNCT06725953 · lead sponsor · 2025-03-10
RECRUITING
Relugolix + Enzalutamide Study in High-Risk Prostate CancerNCT06130995 · lead sponsor · 2024-12-26
RECRUITING
Impact of Semaglutide on Tobacco Use and Related Health BehaviorsNCT06986993 · lead sponsor · 2024-07-01
RECRUITING
Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic ChemotherapyNCT05921253 · lead sponsor · 2023-12-01
RECRUITING
Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma ExacerbationNCT06137040 · lead sponsor · 2023-11-30
RECRUITING
Neuromodulation of Inflammation and Endothelial FunctionNCT05230732 · lead sponsor · 2022-09-01
RECRUITING
Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)NCT05174052 · lead sponsor · 2022-06-01
RECRUITING
Low Level Tragus Stimulation in Acute Decompensated Heart FailureNCT02898181 · lead sponsor · 2016-09-01
RECRUITING
Spirometric Response to Bronchial Thermoplasty in Patients With Severe AsthmaNCT02241265 · lead sponsor · 2014-02-01
RECRUITING
Analysis of Breath Volatile Organic Compounds Using Mass SpectrometryNCT07732686 · lead sponsor · 2026-10-01
NOT_YET_RECRUITING
Disulfiram in Rheumatoid ArthritisNCT07534332 · lead sponsor · 2026-09-01
NOT_YET_RECRUITING
NAD Supplementation in Parkinson's DiseaseNCT07703137 · lead sponsor · 2026-08-10
ENROLLING_BY_INVITATION
Impact of Chia Seeds on Human Breast Milk CompositionNCT07343908 · lead sponsor · 2026-08-01
NOT_YET_RECRUITING
Smoking Cessation Program for Lao People With HIVNCT07014605 · lead sponsor · 2026-08-01
NOT_YET_RECRUITING
Nebulized AER101 in Pre-op NSCLCNCT07631299 · lead sponsor · 2026-06-01
NOT_YET_RECRUITING
Promoting Active Living Among People With Advanced CancerNCT07238023 · lead sponsor · 2026-02-27
ACTIVE_NOT_RECRUITING
Self-Acceptance and Supportive Accountability for Active Living Among Adults Receiving ChemotherapyNCT07819045 · lead sponsor · 2025-09-10
COMPLETED
Neuromodulation in Patients With Pulmonary Arterial HypertensionNCT06802380 · lead sponsor · 2025-09-01
NOT_YET_RECRUITING
Community Intervention to Improve CVD Risk Factor Control in Young American IndiansNCT06230705 · lead sponsor · 2025-03-01
NOT_YET_RECRUITING
Evaluating Pyrroloquinoline Quinone (PQQ) for Improving Obese Pregnancy OutcomesNCT06245083 · lead sponsor · 2024-12-01
WITHDRAWN
Self-Determination Theory-informed Occupational Therapy Program to Increase Physical Activity Among Survivors of Breast CancerNCT06671730 · lead sponsor · 2024-11-27
COMPLETED
Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate CancerNCT05806814 · lead sponsor · 2023-11-12
ACTIVE_NOT_RECRUITING
Urolithin A Supplementation in Middle-aged Adults With ObesityNCT05921266 · lead sponsor · 2023-10-02
COMPLETED
Virtual Reality Software to Reduce Stress in Cancer PatientsNCT05263648 · lead sponsor · 2023-09-01
WITHDRAWN
Bariatric Education for Women With Obesity and Endometrial CancerNCT05396794 · lead sponsor · 2023-08-30
TERMINATED
Ketogenic Diet in Rheumatoid Arthritis (RA)NCT05799768 · lead sponsor · 2023-04-20
ENROLLING_BY_INVITATION
Prostate Cancer Genius App Education and Home-based PSA Screening for African American MenNCT05331638 · lead sponsor · 2023-02-24
ACTIVE_NOT_RECRUITING
MRI Fusion Biopsy vs. Micro-Ultrasound Guided BiopsyNCT05471128 · lead sponsor · 2023-01-27
ACTIVE_NOT_RECRUITING
Efficacy of Hydrogen Peroxide Gel on Periodontitis With DiabetesNCT05669560 · lead sponsor · 2023-01-20
WITHDRAWN
Metabolic Pathology of Pediatric NAFLDNCT05430178 · lead sponsor · 2022-05-25
UNKNOWN
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient PopulationNCT05863052 · lead sponsor · 2022-01-31
ACTIVE_NOT_RECRUITING
Tribally Engaged Approaches to Lung Screening (TEALS)NCT04948060 · lead sponsor · 2022-01-01
ACTIVE_NOT_RECRUITING
The Effect of Different Low-Level Tragus Stimulation Parameters On Autonomic Nervous System FunctionNCT04682704 · lead sponsor · 2021-11-30
UNKNOWN
Magnesphere for Autonomic AlterationNCT04207476 · lead sponsor · 2021-07-25
WITHDRAWN
Diabetes Smoking Cessation Incentives StudyNCT04682067 · lead sponsor · 2021-01-08
COMPLETED
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for OklahomaNCT05208671 · lead sponsor · 2020-10-09
COMPLETED
Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer PatientsNCT04397614 · lead sponsor · 2020-07-22
COMPLETED
Acupuncture Treatment on Cerebral Blood FlowNCT04346511 · lead sponsor · 2020-05-09
WITHDRAWN
Neuromodulation of Inflammation and Vascular Function in Systolic Heart FailureNCT03945058 · lead sponsor · 2020-02-04
TERMINATED
Functional Intermuscular Reduction of SpasticityNCT04403594 · lead sponsor · 2019-08-19
COMPLETED
The Produce Drop: Using Food as Medicine to Lower A1C Levels and Blood PressureNCT04421755 · lead sponsor · 2019-07-16
COMPLETED
Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at TermNCT03801252 · lead sponsor · 2018-12-12
COMPLETED
Incentivized Smoking Cessation for DiabeticsNCT03527667 · lead sponsor · 2018-06-22
COMPLETED
The Effects of a Low Carbohydrate, Non-Ketogenic Diet Versus Standard Diabetes Diet on Glycemic Control in Type 1 DiabetesNCT03544892 · lead sponsor · 2018-05-01
TERMINATED
Neuromodulation to Treat Patients With Heart Failure With Preserved Ejection FractionNCT03327649 · lead sponsor · 2017-12-12
COMPLETED
Effect of Transcutaneous Vagal Stimulation (TVS) on Endothelial Function and Arterial Stiffness in HFrEFNCT03380156 · lead sponsor · 2017-12-04
COMPLETED
Smartphone-delivered Automated Video-assisted Smoking Treatment for People Living With HIVNCT03082482 · lead sponsor · 2017-05-15
COMPLETED
Noninvasive Neuromodulation to Reserve Diastolic DysfunctionNCT02983448 · lead sponsor · 2016-12-01
COMPLETED
Tribal Health and Resilience in Vulnerable EnvironmentsNCT03311217 · lead sponsor · 2016-06-01
COMPLETED
HFNC Effect on BCSS in Patients With COPDNCT02825043 · lead sponsor · 2016-02-01
TERMINATED
Intensive Management for Gestational DiabetesNCT02530866 · lead sponsor · 2015-11-01
COMPLETED

Drugs studied in this sponsor's trials

11 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing University of Oklahoma as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
placebo5
azithromycin2
iloprost2
atazanavir1
cefazolin1
dapagliflozin 10 MG Oral Tablet1
ibuprofen1
lopinavir / ritonavir1
placebo RxCUI 8375 · Lead sponsor in 5 linked trial(s) · 3 currently recruiting 5 trials azithromycin RxCUI 18631 · Lead sponsor in 2 linked trial(s) · 1 currently recruiting 2 trials iloprost RxCUI 40138 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials atazanavir RxCUI 343047 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial cefazolin RxCUI 2180 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial dapagliflozin 10 MG Oral Tablet RxCUI 1488569 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial ibuprofen RxCUI 5640 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial lopinavir / ritonavir RxCUI 284640 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial orlistat RxCUI 37925 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial semaglutide RxCUI 1991302 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial triamcinolone acetonide RxCUI 10761 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor81
collaborator25
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.